Abeona Therapeutics Inc.ABEONASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P36
Within normal range
vs 2Y Ago
-3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.97% |
| 2024 | 10.51% |
| 2023 | 7.34% |
| 2022 | -25.21% |
| 2021 | 28.49% |
| 2020 | -43.94% |
| 2019 | 38.94% |
| 2018 | 127.78% |
| 2017 | 59.45% |
| 2016 | 125.98% |